US stock futures are trading mixed this morning. Some major stocks declined in today’s pre-market trading session.
- Esperion Therapeutics, Inc. espr Shares up 30.7% in pre-market trading after the company reported full results of the ACL-Inhibiting Regimen (CLEAR) trial, a landmark cholesterol-lowering via bempedoic acid, presented at the American College of Cardiology’s Annual Scientific Sessions declined to $4.38. & Expo simultaneously with the World Congress of Cardiology as well as published in the New England Journal of Medicine.
- Diversified Healthcare Trust DHC It fell 5.5% to $1.56 in pre-market trading after gaining more than 11% on Friday. Diversified Healthcare recently reported better-than-expected fourth-quarter sales results.
- Novavax, Inc. NVAX Shares fell 4.2% to $7.37 in pre-market trading after jumping 11% on Friday. Novavax recently reported worse-than-expected Q4 results and said substantial doubt exists about its ability to continue as a going concern.
don’t forget to check out our premarket coverage here
- Hua Inc. happened Shares fell 4.1% to $4.7 in pre-market trading. On the evening of March 4, 2023, Hua hosted the annual gala “Hua Boom Night” at the Cotai Arena of the Venetian Macao in Macao, South China.
- Rio Tinto Group Rio Shares fell 3.6% to $72.48 in pre-market trading. Rio Tinto recently slashed its dividend following weak FY22 results on weak demand for iron ore, aluminum and copper from lockdown-hit China.
- signature bank SBNY Shares fell 3.3% to $110.01 in pre-market trading. Signature Bank recently hired COO Eric R. Howell to succeed Joseph DePaolo as chairman.
- Siboney Stillwater Limited sbsw It fell 3.2% to $8.19 in pre-market trading after a 4% gain on Friday. Sibanye Stillwater recently reported declining fiscal year earnings.
Now read this: Top 5 real estate stocks that are set to take off in March
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.